Related Experiment Video
Updated: Oct 12, 2025

10:06
Author Spotlight: Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry
Published on: March 24, 2023
2.6K
Synthesis and Applications of Porphyrin-Biomacromolecule Conjugates.
Pravin Pathak1, Mohammad Amin Zarandi1, Xiao Zhou1
1Department of Chemistry, Tulane University, New Orleans, LA, United States.
Frontiers in Chemistry
|November 25, 2021
Summary
This review explores methods for attaching porphyrin molecules to biomacromolecules like oligonucleotides and proteins. These hybrid systems show promise in cancer treatment and materials science.
Area of Science:
- Bioconjugation Chemistry
- Materials Science
- Biomedical Engineering
Background:
- Porphyrinoids are crucial for light-responsive applications, particularly in targeted cancer therapy.
- Covalent conjugation of porphyrinoids to biomacromolecules is essential for developing advanced materials and biomedical tools.
- Diverse biomacromolecules (oligonucleotides, peptides, proteins, antibodies) require tailored conjugation strategies due to their unique structures and properties.
Purpose of the Study:
- To review key synthetic approaches for conjugating porphyrinoids with oligonucleotides and peptides/proteins.
- To discuss the applications of these porphyrinoid-biomacromolecule conjugates.
- To provide an overview of porphyrin-antibody conjugates and future directions in the field.
Main Methods:
- Review of synthetic strategies for porphyrinoid conjugation, including bioorthogonal chemistry (e.g., phosphoramidites, click chemistry, Staudinger ligation, alkyne-azide cycloadditions).
- Discussion of conjugation approaches utilizing native functional groups (thiols, amines) and de novo introduced functional groups.
- Analysis of methods for tethering porphyrins to oligonucleotides via solid-phase synthesis or post-synthesis modifications.
- Examination of conjugation techniques for peptides and proteins, emphasizing site-specific strategies.
Main Results:
- Oligonucleotide-porphyrin conjugates are explored for nanostructure self-assembly and artificial light-harvesting, with emerging clinical applications in antimicrobial biomaterials and nucleic acid cleavage.
- Porphyrin-peptide/protein conjugates are predominantly used in therapeutic and diagnostic applications, including photodynamic therapy (PDT), photodynamic antimicrobial chemotherapy (PACT), and photothermal therapy (PTT).
- Porphyrin-antibody conjugates represent a rapidly advancing area with significant therapeutic potential.
Conclusions:
- Tailored synthetic approaches are critical for effective porphyrinoid conjugation to diverse biomacromolecules.
- Porphyrinoid-bioconjugation chemistry is advancing from basic research towards clinically relevant applications.
- Continued innovation in synthetic strategies will drive future developments in porphyrinoid-biomacromolecule conjugates for materials and medicine.

